← FDA Drug Approvals (Drugs@FDA)
APREPITANT
NDA · New Drug Application · Sponsor: AZURITY · Approved 2024-07-25
Drug application
- FDA Application #
NDA218754- Application type
- New Drug Application
- Brand name
- APREPITANT
- Generic name
- Aprepitant
- Active ingredients
- APREPITANT
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- None (Tentative Approval)
- Sponsor
- AZURITY
- First approval
- 2024-07-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown